Cambridge Quarterly of Healthcare Ethics

Table of Contents - 2007 - Volume 16, Issue 02  


SPECIAL SECTION: NEUROETHICS

Internet Marketing of Neuroproducts: New Practices and Healthcare Policy Challenges

ERIC  RACINE  a1 , HZ ADRIAAN  VAN DER LOOS  a2 and JUDY  ILLES  a3
a1 Institut de Recherches Cliniques de Montreal, Canada
a2 Stanford University, and Kehillah Jewish High School in Palo Alto
a3 Stanford University

Article author query
racine e   [PubMed][Google Scholar] 
van der loos ha   [PubMed][Google Scholar] 
illes j   [PubMed][Google Scholar] 

Direct-to-consumer advertising (DTCA) of healthcare products refers to a variety of marketing practices based on a combination of information and promotion strategies directed at consumers through different media such as radio and television broadcasts, newspaper and magazine ads, and, more recently, through the Internet. The principal form of marketing used by the pharmaceutical industry is the distribution of free samples to physicians but DTCA is an increasing part of global promotional spending for prescription drugs. Latest estimates suggest that DTCA now represents an annual $3.2 billion enterprise for the U.S. pharmaceutical industry. Findings from the literature show that these substantial efforts are geared toward the newer pharmaceuticals for chronic conditions with huge market potentials. The lion's share is going to the 20 most prescribed pharmaceuticals. a


Footnotes

a We thank the Henry J. Kaiser Family Foundation (J.I.) for funding of this project and Dr. Patricia King for her support. Writing of this paper was supported by NIH/NINDS R01 #NS045831 (J.I.) and the Social Sciences and Humanities Research Council of Canada (E.R.). We also acknowledge Dr. Pamela Schraedley-Desmond, Shilpa Gulati, Neil Mukhopadhyay, and Sarah Waldman.


User Comments (0)
--